Virus-Like Particles (VLPs) are nanoparticles that closely resemble viruses, but are not infectious. They play a great role in prophylactic medicine as immunity inducing agents and are known to be extremely effective by providing long-term immunity. However, VLPs are not widely available for a range of pathogenic diseases due to high production costs and complexities in vaccine manufacturing processes.

We at The Croma Foundry aim to reduce the complexity and cost of VLP based vaccine production using our next-gen VLP production platform, while simultaneously reducing production time and increasing availability.